(IN BRIEF) Evonik is investing €80 million to expand its biotechnology capabilities at its Fermas site in Slovenská Ľupča, Slovakia, adding advanced downstream fermentation technology to support pharmaceutical drug substance manufacturing. The move responds to increasing demand for complex pharmaceutical … Read the full press release
